tirzepatide and ulcerative colitis Current Pharmacologic Options Emerging Therapeutic Approaches for the Management of Colitis: A Narrative Review Tirzepatide for Weight Loss with

Cureus (2023)

Factors That May Affect Appropriateness According to general clinical guidance referenced in published sources, growth hormone secretagogues may not be appropriate for individuals with certain contraindications including active malignancies, uncontrolled diabetes, or other conditions that a clinician would evaluate during the prescribing process

Data availability The data supporting the findings of this study are available from the corresponding authors upon request

110 Lucken-ArdjomandeS.MontessuitS.MartinouJ

Better tolerability translates to higher adherence rates, longer treatment duration, and ultimately better outcomes

Your GLP1 + GIP medication Home delivery or local pharmacy pickup, depending on your plan